Berberine reduced the expression of NF-κB (Figure 1) in cultured mouse podocytes genetically modified to overexpress tumor necrosis factor (TNF) receptor-associated factor 5 (TRAF5), mimicking the raised levels of TRAF5 in CKD patients. Here, TRAF5 is linked to chronic kidney disease.